141 related articles for article (PubMed ID: 6466567)
1. Prediction of response of acute nonlymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.
Preisler HD; Epstein J; Barcos M; Priore R; Raza A; Browman GP; Vogler R; Winton E; Grunwald H; Rai K
Br J Haematol; 1984 Sep; 58(1):19-32. PubMed ID: 6466567
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia.
Preisler HD; Azarnia N; Raza A; Grunwald H; Vogler R; Browman G; Goldberg J; Chervenick P; Miller K; Brennan J
Br J Haematol; 1984 Mar; 56(3):399-407. PubMed ID: 6582925
[TBL] [Abstract][Full Text] [Related]
3. Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements.
Preisler HD; Priore R; Azarnia N; Barcos M; Raza A; Rakowski I; Vogler R; Winton EL; Browman G; Goldberg J
Br J Haematol; 1986 Aug; 63(4):625-36. PubMed ID: 3460626
[TBL] [Abstract][Full Text] [Related]
4. High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.
Preisler HD; Raza A; Barcos M; Azarnia N; Larson R; Walker I; Browman M; Grunwald H; D'Arrigo P; Doeblin T
J Clin Oncol; 1987 Jan; 5(1):75-82. PubMed ID: 3806162
[TBL] [Abstract][Full Text] [Related]
5. Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: relationship to response to remission induction therapy.
Preisler HD; Raza A; Azarnia N; Rakowsky I; Barcos M; Browman G; Booker L; Goldberg J; Gottleib A; Brennan J
Eur J Cancer Clin Oncol; 1985 May; 21(5):563-71. PubMed ID: 3859416
[TBL] [Abstract][Full Text] [Related]
6. Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup study.
Browman G; Preisler H; Raza A; Syracuse K; Azarnia N; Benger A; Chervenick P; D'Arrigo P; Doeblin T; Goldberg J
Br J Haematol; 1989 Apr; 71(4):493-7. PubMed ID: 2653407
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the drug sensitivity of acute nonlymphocytic leukaemia using the in vitro clonogenic assay.
Preisler HD; Azarnia N
Br J Haematol; 1984 Dec; 58(4):633-40. PubMed ID: 6518136
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside.
Preisler HD; Rustum YM; Azarnia N; Priore R
Cancer Chemother Pharmacol; 1987; 19(1):69-74. PubMed ID: 3815728
[TBL] [Abstract][Full Text] [Related]
9. An attempt at synchronization of marrow cells in acute leukemia: relationship to therapeutic response.
Kremer WB; Vogler WR; Chan YK
Cancer; 1976 Jan; 37(1):390-403. PubMed ID: 1082365
[TBL] [Abstract][Full Text] [Related]
10. Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients.
Tilly H; Castaigne S; Bordessoule D; Sigaux F; Daniel MT; Monconduit M; Degos L
Cancer; 1985 Apr; 55(8):1633-6. PubMed ID: 3978558
[TBL] [Abstract][Full Text] [Related]
11. Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia.
Preisler HD; Raza A; Larson R; Browman G; Goldberg J; Grunwald H; Vogler R; Bennett J; Gottlieb A; D'Arrigo P
Cancer Chemother Pharmacol; 1986; 18(3):257-60. PubMed ID: 3802381
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects of aneuploidy on the outcome of remission induction therapy for acute nonlymphocytic leukaemia: analysis of types of treatment failure.
Preisler HD; Reese PA; Marinello MJ; Pothier L
Br J Haematol; 1983 Mar; 53(3):459-66. PubMed ID: 6824587
[TBL] [Abstract][Full Text] [Related]
13. Prediction of response of acute non-lymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.
Peters WG; Willemze R; Colly LP; Colla L
Br J Haematol; 1985 Apr; 59(4):733-4. PubMed ID: 3857074
[No Abstract] [Full Text] [Related]
14. Low dose cytosine arabinoside: partial remission of acute myeloid leukaemia without evidence of differentiation induction.
Leyden M; Manoharan A; Boyd A; Cheng ZM; Sullivan J
Br J Haematol; 1984 Jun; 57(2):301-7. PubMed ID: 6587903
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of DNA synthesis by cytosine arabinoside: relation to response of acute non-lymphocytic leukemia to remission induction therapy and to stage of the disease.
Preisler HD; Epstein J; Raza A; Azarnia N; Browman G; Booker L; Goldberg J; Gottlieb A; Brennan J; Grunwald H
Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1061-8. PubMed ID: 6540689
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with acute nonlymphocytic leukemia in relapse: a Leukemia Intergroup study.
Goldberg J; Grunwald H; Vogler WR; Winton E; Browman G; Walker I; Benger A; Miller KB; Rai K; Gottlieb AJ
Am J Hematol; 1985 Jun; 19(2):167-76. PubMed ID: 3890525
[TBL] [Abstract][Full Text] [Related]
17. Treatment of "poor risk" acute nonlymphocytic leukemia with continuously infused low-dose cytosine arabinoside.
Balaban EP; Cox JV; Schneider NR; Harth CA; Haley BB; Sheehan R; Frenkel EP
Am J Hematol; 1988 Oct; 29(2):79-84. PubMed ID: 3189306
[TBL] [Abstract][Full Text] [Related]
18. Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
Harris AL; Grahame-Smith DG; Potter CG; Bunch C
Clin Sci (Lond); 1981 Feb; 60(2):191-8. PubMed ID: 6940687
[TBL] [Abstract][Full Text] [Related]
19. Low-dose cytosine arabinoside in the treatment of acute nonlymphoblastic leukemia and myelodysplastic syndromes.
Hoelzer D; Ganser A; Schneider W; Heimpel H
Semin Oncol; 1985 Jun; 12(2 Suppl 3):208-11. PubMed ID: 4012339
[No Abstract] [Full Text] [Related]
20. Cell proliferation and protein synthesis in human leukaemic myeloblasts after cytosine arabinoside therapy.
Wantzin GL; Karle H; Killmann SA
Br J Haematol; 1976 Feb; 32(2):283-9. PubMed ID: 1061618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
